MétaCan
Menu
Back to cohort
Record W4389390606 · doi:10.21203/rs.3.rs-3705016/v1

The Effects of Short-Chain Fatty Acid-Butyrate Supplementation on the Expression of Circadian-Clock Genes and Sleep Quality in Patients with Active Ulcerative Colitis: A Double-Blind Randomized Controlled Trial

2023· preprint· en· W4389390606 on OpenAlexaff
Donya Firoozi, Seyed Jalil Masoumi, Seyed Mohammad Kazem Hosseini Asl, Aurélie Labbe, Kamran Bagheri Lankarani, Iman Razeghian‐Jahromi, Mahintaj Dara, Mohammad Fararouei

Bibliographic record

VenueResearch Square · 2023
Typepreprint
Languageen
FieldMedicine
TopicDietary Effects on Health
Canadian institutionsUniversité de Montréal
FundersShiraz UniversityShiraz University of Medical SciencesIran National Science FoundationNational Science Foundation
KeywordsMedicineInternal medicineButyrateGastroenterologyPER2Ulcerative colitisPittsburgh Sleep Quality IndexPlaceboCLOCKColitisCircadian clockCircadian rhythmDiseasePharmacologyBiologyPathologyBiochemistry

Abstract

fetched live from OpenAlex

Abstract Background: Emerging evidence suggests that administering short-chain fatty acids-butyrate could be effective in managing inflammatory bowel disease (IBD), particularly in the regulation of circadian-clock genes, an area of focus in the etiology of IBD. This study was conducted to investigate the effects of sodium butyrate supplementation on the expression of circadian-clock genes, inflammation, sleep and life quality in active ulcerative colitis (UC) patients. Methods: In the current randomized controlled trial, 36 active UC patients were randomly divided to receive sodium butyrate (600 mg/kg) or placebo for 12-weeks. Before enrolling the first participant, the study received ethical approval from the Research Ethics Committee of Shiraz University of Medical Sciences (reference number: IR.SUMS.SCHEANUT.REC.1400.037) in October 2021, it was registered on IRCT.ir with the registration number IRCT20211214053401N1 on January 1st, 2022. We assessed the expression of circadian clock genes (CRY1, CRY2, PER1, PER2, BMAl1 and CLOCK) by real time polymerase chain reaction (qPCR) in blood as well as faecal calprotectin and serum level of high-sensitivity C-reactive protein (hs-CRP) by enzyme-linked immunosorbent assay method (ELIZA). Moreover, the sleep quality and IBD quality of life (QoL) were assessed by Pittsburgh sleep quality index (PSQI) and inflammatory bowel disease questionnaire-9 (IBDQ-9) respectively before and after the intervention. Results: The results showed that butyrate supplementation in comparison with placebo significantly upregulated the fold change expression of CRY1 (2.22 (1.59) vs. 0.63 (0.49), p-value < 0.001), CRY2 (2.15 (1.26) vs. 0.93 (0.80), p-value= 0.001), PER1 (1.86 (1.77) vs. 0.65 (0.48), p-value= 0.005), BMAL1 (1.85 (0.97) vs. 0.86 (0.63), p-value= 0.003) and decreased the level of calprotectin (-133.82 (155.62) vs. 51.58 (95.57), p-value <0.001) and hs-CRP (-0.36 (-1.57, -0.05) vs. 0.48 (-0.09-4.77), p-value <0.001). Also, butyrate caused an improvement in the sleep quality (PSQI score: -2.94 (3.50) vs. 1.16 (3.61), p-value <0.001) and QoL (IBDQ-9: 17.00 (11.36) vs. -3.50 (6.87), p-value <0.001). Conclusion: Butyrate may be an effective adjunct treatment for active UC patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.006
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.066
Threshold uncertainty score0.788

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0130.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.075
GPT teacher head0.427
Teacher spread0.351 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueResearch SquareSame topicDietary Effects on HealthFrench-language works237,207